Latest Geographic Expansion News

Telix Pharmaceuticals has achieved a key milestone with China’s NMPA accepting its New Drug Application for Illuccix, a prostate cancer imaging agent backed by strong Phase 3 data. This paves the way for Telix to enter a rapidly growing Chinese market alongside its global approvals.

Love Group Global Ltd has reported record operating profits in Q2 FY26, driven by growth in Hong Kong and marketing efficiencies, while planning to expand its matchmaking services into new international markets.

Symal Group has agreed to acquire an 80% stake in South Australian civil contractor Davison Earthmovers for $23.2 million, marking a strategic entry into a region with a booming infrastructure pipeline.

RAS Technology Holdings will not renew its Complete Racing Solution contract with Stake in 2026, shifting focus to expanding in regulated markets and Asia’s burgeoning racing sector.

Steadfast Group reveals robust acquisition activity and strategic cost optimizations in its latest investor update, signaling strong momentum across its Australasian and international operations.

De.mem Limited has successfully integrated Core Chemicals Pty Ltd, exceeding initial revenue expectations and setting the stage for geographic and sector expansion in the Australian gold mining chemicals market.

Verbrec Limited has completed the sale of its Competency Training business for $11.2 million, positioning itself for strategic growth in energy transition and automation sectors.

Nex Metals Explorations reported no exploration spending in Q1 FY26 but made significant strides by finalising a profit-sharing deal for its Kookynie project and entering Egypt’s Eastern Desert mining scene.

TechnologyOne has reported a robust FY25 with profit before tax up 19% and ARR reaching $554.6 million, propelled by its SaaS+ platform and UK market expansion. The company sets an ambitious $1 billion ARR target by FY30, underpinned by strong R&D investment and AI integration.

Resonance Health has revealed ambitious growth plans at its 2025 AGM, projecting revenue to nearly quadruple by FY26 while maintaining positive EBITDA guidance. The company is broadening its global footprint and diversifying its clinical trial services across multiple therapeutic areas.

NRW Holdings showcased strong FY25 proforma results and ambitious FY26 guidance at the UBS Conference, underpinned by strategic acquisitions and a diversified portfolio. The company’s growth strategy focuses on expanding capabilities in energy transition and infrastructure markets across Australia, New Zealand, and North America.

Zoono Group has secured a five-year exclusive contract with Mpact Operations to apply its antimicrobial technology to corrugated packaging for fresh produce in South Africa and Namibia, aiming to extend shelf-life and reduce food waste.